- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 6.81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.81M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 6.96M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $55K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $163K |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $2.49M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $2.09M |
| Capex | Q1 2026 · Mar 31, 2026 | $274K |
| Capex | Q1 2026 · Mar 31, 2025 | $200K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $5.21M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.25M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $119.79M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $135.69M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $67.67M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $117.35M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $273.6M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $270.71M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $266.99M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $262.04M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.98B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.01B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.25B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.29B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.91 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.77 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.92 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.78 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $131K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $110K |
| Net Income | Q1 2026 · Mar 31, 2026 | $6.23M |
| Net Income | Q1 2026 · Mar 31, 2025 | $5.38M |